Professional Society Guidelines

Use of CGM in Pediatrics – A Consensus Statement

Consensus Statement, Pediatric Diabetes (2012) 

This consensus statement has been developed by a world-wide expert panel of pediatric endocrinologists and represents the clinical guidance of the use of continuous glucose monitoring (CGM) from the European Society for Pediatric Endocrinology, the Pediatric Endocrine Society and the International Society for Pediatric and Adolescent Diabetes. Use of real-time CGM provides the following benefits: 

  • Improved overnight control with hypoglycemia alarms 
  • Enhanced understanding of diabetes management teaching 
  • Improved daytime bolus dosing with trend arrows and hyper- and hypoglycemia alarms for real-time adjustements 
  • Improved management of acute illnesses 

Source: Phillip M, Danne T, Shalitin S, Buckingham B, Laffel L, Tamboralne W, Battelino T and Consensus Forum Participants. Pediatric Diabetes, 2012. 

Related Content

Contact Us

If you are a healthcare provider and want to learn more about Dexcom, please fill out the form and a representative will contact you. If you are a Dexcom User or Patient, please contact Dexcom here.

 

By choosing to request info, you are granting Dexcom, Inc. permission to process your personal information to send you additional information and promotional communications related to Dexcom products. You may opt-out of these communications at any time. Dexcom respects the privacy and confidentiality of your personal information. The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.